Provided by Tiger Trade Technology Pte. Ltd.

Soligenix, Inc.

1.65
+0.02001.23%
Post-market: 1.57-0.0800-4.85%19:38 EST
Volume:356.83K
Turnover:581.73K
Market Cap:16.64M
PE:-0.39
High:1.70
Open:1.63
Low:1.56
Close:1.63
52wk High:6.23
52wk Low:1.09
Shares:10.09M
Float Shares:7.93M
Volume Ratio:0.87
T/O Rate:4.50%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.2455
EPS(LYR):-4.9786
ROE:-165.10%
ROA:-69.38%
PB:2.19
PE(LYR):-0.33

Loading ...

Soligenix Inc. Closes $7.5 Million Public Offering to Extend Cash Runway Through 2026

Reuters
·
Sep 30

Soligenix Announces Closing of $7.5 Million Public Offering

THOMSON REUTERS
·
Sep 30

BRIEF-Soligenix Announces Pricing of $7.5 Million Public Offering

Reuters
·
Sep 26

Soligenix Announces $7.5 Million Public Offering of Common Stock and Warrants to Fund R&D and Corporate Activities

Reuters
·
Sep 26

Soligenix Inc - Offers 5,555,560 Shares of Common Stock and Warrants at $1.35 Each

THOMSON REUTERS
·
Sep 26

Soligenix Inc. Appoints Former White House Economic Adviser Tomas J. Philipson, PhD as Strategic Advisor

Reuters
·
Sep 23

Soligenix Announces Appointment of Former White House Economic Adviser Tomas J. Philipson, Phd as Strategic Advisor

THOMSON REUTERS
·
Sep 23

Soligenix files to sell 2.91M shares of common stock, 2.91M warrants

TIPRANKS
·
Sep 20

BRIEF-Soligenix Announces Publication Describing Long-Term High Temperature Stability Of Protein Subunit Vaccines For Ebola And Related Viruses

Reuters
·
Sep 04

Soligenix Announces Publication Describing Long-Term High Temperature Stability of Protein Subunit Vaccines for Ebola and Related Viruses

THOMSON REUTERS
·
Sep 04

Soligenix Inc. Unveils Corporate Presentation Focused on Advancements in Rare Disease Treatment and Robust Pipeline

Reuters
·
Aug 22

Top Midday Gainers

MT Newswires Live
·
Aug 19

BUZZ-U.S. STOCKS ON THE MOVE-Soligenix, BioXcel, GoodRx

Reuters
·
Aug 18

Soligenix Shares Gain 36% on FDA's Orphan Drug Tag for Behcet's Disease Therapy

THOMSON REUTERS
·
Aug 18

Shares of Soligenix Rise 55.8% Premarket on FDA's Orphan Drug Tag for Behcet's Disease Therapy

THOMSON REUTERS
·
Aug 18

BUZZ-Soligenix jumps on FDA's orphan drug tag for Behcet's disease therapy

Reuters
·
Aug 18

Soligenix Inc. Receives FDA Orphan Drug Designation for SGX945 in the Treatment of Behçet's Disease, Securing Seven Years of Market Exclusivity

Reuters
·
Aug 18

FDA Grants Soligenix Orphan Drug Designation for the Treatment of BehÇEt's Disease After Reviewing Recent Phase 2 Clinical Study Results

THOMSON REUTERS
·
Aug 18

BRIEF-Soligenix Inc Receives Nasdaq Notice For Non-Compliance With Equity Requirement

Reuters
·
Aug 16

Soligenix Inc - Receives Nasdaq Notice for Non-Compliance With Equity Requirement - SEC Filing

THOMSON REUTERS
·
Aug 16